Displaying items 13-24 of 1626
» View wsbtradio.com items only
< Previous
•
1
2
3
4
5
6
7
8
9
10
11-136
•
Next >
-
Labs reject dramatic findings on cancer drug in Alzheimer's mice
ReutersCHICAGO (Reuters) - U.S. scientists say a dramatic result last year suggesting that a cancer drug already approved by U.S. regulators could quickly clear out Alzheimer's plaques in mice was too good to be true. The study, published last year in the...Tags: Skin Cancer, Massachusetts General Hospital, University of Pittsburgh, Health and Safety at School, Colleges and Universities
-
Ranbaxy slumps after Daiichi Sankyo says was misled
ReutersMUMBAI (Reuters) - Shares in Ranbaxy Laboratories Ltd fell as much as 10.7 percent on Thursday after majority shareholder Daiichi Sankyo Co said it believed former shareholders of the Indian company hid information regarding U.S. regulatory probes....Tags: Companies and Corporations, Mumbai (India), Japan, Shareholders, Crime, Law and Justice
-
Forest Labs' longtime CEO Solomon to step down at year-end
Reuters(Reuters) - Forest Laboratories Inc said Howard Solomon, its chief executive of more than 35 years, will retire at the end of this year, capping a tenure that saw the company morph from a small generic and vitamins maker to a $10 billion corporation....Tags: Howard Solomon, Companies and Corporations, Board of Directors, NYSE Euronext, Inc., Forest Laboratories Incorporated
-
Howard County pets: What's the hype about raw diets?
Q: I’ve heard a lot about raw dog food, but it seems pricey. Is it safe? Are the health benefits substantial? A: Raw diets for dogs (including raw meat) have become increasingly popular. Some pet owners -- even some veterinarians -- swear by them,...
Tags: Diets and Dieting, Herbal Supplements, Animal Science, Health Organizations, Arable Farming
-
The Doctor's Corner: An early start on treating menopause
This is the first of a two-part series updating women of all ages on the use of hormones. It is a pleasure to be back putting pencil to paper with good news for women going through "the change." A Global Consensus Statement, hot off the press in the...Tags: Gynecology, Fatigue, Medical Specialization, Osteoporosis, Physical Conditions
-
NCJW disappointed by 'pill' restrictions
Not since "the pill" became widely available in the 60s, has there been such a battle over birth control than the one currently being waged over "Plan B" emergency contraception and its restrictions. Moreover, following the Food and Drug Administration...Tags: Immigration, Personal Income, Judaism, Science and Technology, Health Treatments
-
AcelRX post-op pain treatment meets late-stage study goal
Reuters(Reuters) - AcelRX Pharmaceuticals Inc said its experimental treatment for post-operative pain met its main goal in a late-stage trial of patients who had undergone knee or hip replacement surgery, sending its shares up 15 percent. AcelRX said its...Tags: Placebo, Drugs and Medicines, Hip Replacement, Trials
-
FDA PANEL: MERCK SHOULD NOT HAVE TO PERFORM
ReutersFDA PANEL: MERCK SHOULD NOT HAVE TO PERFORM ADDITIONAL CLINICAL STUDIES OF THE 10 MG DOSE OF INSOMNIA DRUG SUVOREXANT -
Amazon wins key cloud security clearance from U.S. government
ReutersBy Alistair Barr SAN FRANCISCO, May 21 (Reuters) - Amazon.com Inc has been given a security clearance by the U.S. government that will make it easier for federal agencies to use its cloud computing services. Amazon Web Services, known as AWS, was...Tags: Government, National Government, Politics, Amazon.com Inc.
-
FDA PANEL: MERCK'S INSOMNIA DRUG SUVOREXANT IS
ReutersFDA PANEL: MERCK'S INSOMNIA DRUG SUVOREXANT IS SAFE TO BE STARTED AT 15 MG IN THE ELDERLY AND 20 MG IN NON-ELDERLY PATIENTS -
FDA PANEL: MERCK'S EXPERIMENTAL INSOMNIA DRUG
ReutersFDA PANEL: MERCK'S EXPERIMENTAL INSOMNIA DRUG SUVOREXANT IS NOT SAFE AT HIGHER DOSES IN PATIENTS WHO DO NOT RESPOND TO LOWER DOSES -
FDA panel: Merck's insomnia drug effective, safe at low doses
ReutersWASHINGTON, May 22 (Reuters) - Merck & Co's experimental insomnia drug is safe and effective at the lower of two doses studied but not at the higher, a panel of medical experts said on Wednesday. The panel, which advises the U.S. Food and Drug...Tags: Merck & Company Incorporated, Insomnia
May 23, 2013
|Story| Reuters
May 23, 2013
|Story| Reuters
May 23, 2013
|Story| Reuters
May 22, 2013
|Story| Baltimore Sun
May 21, 2013
|Story| Coastline Pilot
May 21, 2013
|Story| South Florida Sun-Sentinel
May 21, 2013
|Story| Reuters
May 22, 2013
|Story| Reuters
May 20, 2013
|Story| Reuters
May 22, 2013
|Story| Reuters
May 22, 2013
|Story| Reuters
May 22, 2013
|Story| Reuters
Original site for Food and Drug Administration topic gallery.